EVPL and atherosclerosis: To test the hypothesis that autoantibodies against native p210 protect against atherosclerosis, we either immunized atherosclerotic apoE-/- mice with apoB100 p210 conjugated to Pan-DR T cell epitopes (PADRE), a potent immunogenic amino acid sequence14–16, or treated them with a monoclonal antibody specifically targeted against apoB100 p210.